Radionuclide Imaging for Neuroscience: Current Opinion and Future Directions

Antony D. Gee PhD; Matthias M. Herth PhD; Michelle L. James PhD; Aruna Korde PhD; Peter J. H. Scott PhD; Neil Vasdev PhD

doi:10.1177/1536012120936397

Molecular Imaging (Sep 2020)

Radionuclide Imaging for Neuroscience: Current Opinion and Future Directions

Antony D. Gee PhD,
Matthias M. Herth PhD,
Michelle L. James PhD,
Aruna Korde PhD,
Peter J. H. Scott PhD,
Neil Vasdev PhD

Affiliations

Antony D. Gee PhD: Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, , United Kingdom
Matthias M. Herth PhD: Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark
Michelle L. James PhD: Department of Neurology and Neurological Sciences, , Palo Alto, CA, USA
Aruna Korde PhD: Radioisotope Products and Radiation Technology Section, Division of Physical and Chemical Sciences, Department of Nuclear Sciences and Applications, , Vienna International Centre, Vienna, Austria
Peter J. H. Scott PhD: Department of Radiology, , Ann Arbor, MI, USA
Neil Vasdev PhD: Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, , Toronto, Ontario, Canada

DOI: https://doi.org/10.1177/1536012120936397
Journal volume & issue: Vol. 19

Abstract

Read online

This meeting report summarizes a Consultants Meeting that was held at International Atomic Energy Agency headquarters in Vienna to provide an update on radionuclide imaging for neuroscience applications.

Published in Molecular Imaging

ISSN: 1536-0121 (Online)
Publisher: SAGE Publications
Country of publisher: United States
LCC subjects: Science: Biology (General); Medicine: Medicine (General): Medical technology
Website: https://journals.sagepub.com/home/MIX

About the journal